{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T21:36:20Z","timestamp":1717364180566},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s12253-011-9370-2","type":"journal-article","created":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T00:13:13Z","timestamp":1301530393000},"page":"691-696","source":"Crossref","is-referenced-by-count":13,"title":["Expressions of Topoisomerase II\u03b1 and BCRP in Metastatic Cells are Associated with Overall Survival in Small Cell Lung Cancer Patients"],"prefix":"10.1007","volume":"17","author":[{"given":"Matija","family":"Rijavec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"\u0160ilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja","family":"Triller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izidor","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ur\u0161ka","family":"\u010cegovnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitja","family":"Ko\u0161nik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Koro\u0161ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,1]]},"reference":[{"key":"9370_CR1","unstructured":"National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology: Small cell lung cancer. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/sclc.pdf . Accessed June 3, 2009"},{"key":"9370_CR2","unstructured":"National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology: Non-Small cell lung cancer. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/nscl.pdf . Accessed June 3, 2009"},{"key":"9370_CR3","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1093\/annonc\/10.suppl_5.S83","volume":"10","author":"GV Scagliotti","year":"1999","unstructured":"Scagliotti GV, Novello S, Selvaggi G (1999) Multidrug resistance in non-small-cell lung cancer. Ann Oncol 10:S83\u2013S86","journal-title":"Ann Oncol"},{"key":"9370_CR4","first-page":"156","volume-title":"lung cancer","author":"EF Smith","year":"1995","unstructured":"Smith EF, Postmus PE (1995) Chemotherapy of small cell lung cancer. In: Carney DN (ed) lung cancer. The Bath Press, Avon, pp 156\u2013172"},{"key":"9370_CR5","first-page":"61","volume":"15","author":"DC Ihde","year":"1991","unstructured":"Ihde DC, Minna JD (1991) Non-small cell lung cancer. Part I: biology, diagnosis, and staging. Curr Probl Cancer 15:61\u2013104","journal-title":"Curr Probl Cancer"},{"key":"9370_CR6","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1164\/rccm.200202-070SO","volume":"166","author":"SG Spiro","year":"2002","unstructured":"Spiro SG, Porter JC (2002) Lung cancer-where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 166:1166\u20131196","journal-title":"Am J Respir Crit Care Med"},{"key":"9370_CR7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1248\/bpb.28.707","volume":"28","author":"K Ikuta","year":"2005","unstructured":"Ikuta K, Takemura K, Sasaki K, Kihara M, Nishimura M, Ueda N, Naito S, Lee E, Shimizu E, Yamauchi A (2005) Expression of multidrug resistance proteins and accumulation of cisplatin in human non-small cell lung cancer cells. Biol Pharm Bull 28:707\u2013712","journal-title":"Biol Pharm Bull"},{"key":"9370_CR8","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.4161\/cbt.5.12.3546","volume":"5","author":"H Chhatriwala","year":"2006","unstructured":"Chhatriwala H, Jafri N, Salgia R (2006) A review of topoisomerase inhibition in lung cancer. Cancer Biol Ther 5:1600\u20131607","journal-title":"Cancer Biol Ther"},{"key":"9370_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.bi.58.070189.001033","volume":"58","author":"JA Endicott","year":"1989","unstructured":"Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann Rev Biochem 58:137\u2013171","journal-title":"Ann Rev Biochem"},{"key":"9370_CR10","first-page":"357","volume":"54","author":"CE Grant","year":"1994","unstructured":"Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54:357\u2013361","journal-title":"Cancer Res"},{"key":"9370_CR11","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","volume":"95","author":"LA Doyle","year":"1998","unstructured":"Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95:15665\u201315670","journal-title":"Proc Natl Acad Sci USA"},{"key":"9370_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0005-2736(99)00161-3","volume":"1461","author":"I Klein","year":"1999","unstructured":"Klein I, Sarkadi B, Varadi A (1999) An inventory of the human ABC proteins. Biochim Biophys Acta 1461:237\u2013262","journal-title":"Biochim Biophys Acta"},{"key":"9370_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.lungcan.2006.06.019","volume":"54","author":"N Triller","year":"2006","unstructured":"Triller N, Korosec P, Kern I, Kosnik M, Debeljak A (2006) Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease. Lung Cancer 54:235\u2013240","journal-title":"Lung Cancer"},{"key":"9370_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/1097-0215(20001015)88:2<293::AID-IJC23>3.0.CO;2-S","volume":"88","author":"W Berger","year":"2000","unstructured":"Berger W, Elbling L, Micksche M (2000) Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs. Int J Cancer 88:293\u2013300","journal-title":"Int J Cancer"},{"key":"9370_CR15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0163-7258(99)00073-X","volume":"85","author":"AK Larsen","year":"2000","unstructured":"Larsen AK, Escargueil AE, Skladanowski A (2000) Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 85:217\u2013229","journal-title":"Pharmacol Ther"},{"key":"9370_CR16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1054-3589(08)61134-5","volume":"29","author":"N Osheroff","year":"1994","unstructured":"Osheroff N, Corbett AH, Robinson MJ (1994) Mechanism of action of topoisomerase II-targeted antineoplastic drugs. Adv Pharmacol 29:105\u2013126","journal-title":"Adv Pharmacol"},{"key":"9370_CR17","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1677\/erc.1.01024","volume":"12","author":"PJ Barrett-Lee","year":"2005","unstructured":"Barrett-Lee PJ (2005) Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: a review of chemotherapy. Endocr Relat Cancer 12:S125\u2013S133","journal-title":"Endocr Relat Cancer"},{"key":"9370_CR18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<729::AID-CNCR6>3.0.CO;2-9","volume":"78","author":"DG Guinee Jr","year":"1996","unstructured":"Guinee DG Jr, Holden JA, Benfield JR, Woodward ML, Przygodzki RM, Fishback NF, Koss MN, Travis WD (1996) Comparison of DNA topoisomerase II alpha expression in small cell and nonsmall cell carcinoma of the lung. In search of a mechanism of chemotherapeutic response. Cancer 78:729\u2013735","journal-title":"Cancer"},{"key":"9370_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ncponc0025","volume":"1","author":"L Pusztai","year":"2004","unstructured":"Pusztai L, Gianni L (2004) Technology insight: emerging techniques to predict response to preoperative chemotherapy in breast cancer. Nat Clin Pract Oncol 1:44\u201350","journal-title":"Nat Clin Pract Oncol"},{"key":"9370_CR20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jnci\/95.4.255","volume":"95","author":"B Goldman","year":"2003","unstructured":"Goldman B (2003) Multidrug resistance: can new drugs help chemotherapy score against cancer? J Natl Cancer Inst 95:255\u2013257","journal-title":"J Natl Cancer Inst"},{"key":"9370_CR21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","volume":"8","author":"GD Leonard","year":"2003","unstructured":"Leonard GD, Fojo T, Bates SE (2003) The role of ABC transporters in clinical practice. Oncologist 8:411\u2013424","journal-title":"Oncologist"},{"key":"9370_CR22","first-page":"3052","volume":"9","author":"S Kawabata","year":"2003","unstructured":"Kawabata S, Oka M, Soda H, Shiozawa K, Nakatomi K, Tsurutani J, Nakamura Y, Doi S, Kitazaki T, Sugahara K, Yamada Y, Kamihira S, Kohno S (2003) Expression and functional analyses of breast cancer resistance protein in lung cancer. Clin Cancer Res 9:3052\u20133057","journal-title":"Clin Cancer Res"},{"key":"9370_CR23","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/jnci\/91.19.1647","volume":"91","author":"M Kitazono","year":"1999","unstructured":"Kitazono M, Sumizawa T, Takebayashi Y, Chen ZS, Furukawa T, Nagayama S, Tani A, Takao S, Aikou T, Akiyama S (1999) Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst 91:1647\u20131653","journal-title":"J Natl Cancer Inst"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-011-9370-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-011-9370-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-011-9370-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T06:39:15Z","timestamp":1559457555000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-011-9370-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["9370"],"URL":"https:\/\/doi.org\/10.1007\/s12253-011-9370-2","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,1]]}}}